May 7 , 2023
570 days
471
- The US Food and Drug Administration has approved the first vaccine for respiratory syncytial virus (RSV) for people aged 60 and over.
- It becomes the world's first RSV immunization for adults.
- RSV is a "highly contagious" virus that causes infections of the lungs and breathing passages.
Post Views:
471